Cargando…

Impact of ferumoxytol vs gadolinium on 4D flow cardiovascular magnetic resonance measurements in small children with congenital heart disease

BACKGROUND: Cardiovascular magnetic resonance (CMR) allows for time-resolved three-dimensional phase-contrast (4D Flow) analysis of congenital heart disease (CHD). Higher spatial resolution in small infants requires thinner slices, which can degrade the signal. Particularly in infants, the choice of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kollar, Sarah E., Udine, Michelle L., Mandell, Jason G., Cross, Russell R., Loke, Yue-Hin, Olivieri, Laura J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648014/ https://www.ncbi.nlm.nih.gov/pubmed/36352454 http://dx.doi.org/10.1186/s12968-022-00886-w

Ejemplares similares

4-Dimensional Flow by Cardiac Magnetic Resonance Informs Surgical Planning in Partial Anomalous Pulmonary Venous Return
por: Christopher, Adam, et al.
Publicado: (2020)

Altered hemodynamics by 4D flow cardiovascular magnetic resonance predict exercise intolerance in repaired coarctation of the aorta: an in vitro study
por: Mandell, Jason G., et al.
Publicado: (2021)

Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging
por: Nguyen, Kim-Lien, et al.
Publicado: (2017)

Blood volume measurement using cardiovascular magnetic resonance and ferumoxytol: preclinical validation
por: Ramasawmy, Rajiv, et al.
Publicado: (2018)

Ferumoxytol-enhanced cardiovascular magnetic resonance detection of early stage acute myocarditis
por: Tada, Yuko, et al.
Publicado: (2019)

Ferumoxytol-Enhanced Cardiac Magnetic Resonance Angiography and 4D Flow: Safety and Utility in Pediatric and Adult Congenital Heart Disease
por: Renella, Pierangelo, et al.
Publicado: (2022)

Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis
por: Stirrat, Colin G, et al.
Publicado: (2018)

Normal right and left ventricular volumes prospectively obtained from cardiovascular magnetic resonance in awake, healthy, 0- 12 year old children
por: Olivieri, Laura J., et al.
Publicado: (2020)

High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion
por: Shahrouki, Puja, et al.
Publicado: (2019)

Contemporary sequential segmental approach to congenital heart disease using four-dimensional magnetic resonance imaging with ferumoxytol: an illustrated editorial
por: Yoo, Shi-Joon, et al.
Publicado: (2023)

Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients
por: Stoumpos, Sokratis, et al.
Publicado: (2017)

Ferumoxytol-enhanced magnetic resonance imaging assessing inflammation after myocardial infarction
por: Stirrat, Colin G, et al.
Publicado: (2017)

Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance
por: Leyva, Francisco, et al.
Publicado: (2011)

The current state and potential innovation of fetal cardiac MRI
por: Udine, Michelle, et al.
Publicado: (2023)

Magnetic Resonance Imaging of Ferumoxytol-Labeled Human Mesenchymal Stem Cells in the Mouse Brain
por: Lee, Na Kyung, et al.
Publicado: (2016)

Ferumoxytol-enhanced magnetic resonance imaging methodology and normal values at 1.5 and 3T
por: Stirrat, Colin G., et al.
Publicado: (2016)

Moving beyond size: vorticity and energy loss are correlated with right ventricular dysfunction and exercise intolerance in repaired Tetralogy of Fallot
por: Loke, Yue-Hin, et al.
Publicado: (2021)

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis
por: Lossnitzer, Dirk, et al.
Publicado: (2010)

Dressler's syndrome demonstrated by late gadolinium enhancement cardiovascular magnetic resonance
por: Steadman, Christopher D, et al.
Publicado: (2009)

Accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis
por: Tzogias, Leonidas, et al.
Publicado: (2009)

Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease
por: Stoumpos, Sokratis, et al.
Publicado: (2019)

Imaging Tumor Necrosis with Ferumoxytol
por: Aghighi, Maryam, et al.
Publicado: (2015)

Effects of gadolinium contrast agent on aortic blood flow and myocardial strain measurements by phase-contrast cardiovascular magnetic resonance
por: Hedström, Erik, et al.
Publicado: (2010)

Oxidation of ferumoxytol by ionizing radiation releases iron. An electron paramagnetic resonance study
por: Petronek, Michael S, et al.
Publicado: (2022)

Usage of 3D models of tetralogy of Fallot for medical education: impact on learning congenital heart disease
por: Loke, Yue-Hin, et al.
Publicado: (2017)

Parenteral ferumoxytol interaction with magnetic resonance imaging: a case report, review of the literature and advisory warning
por: Schieda, Nicola
Publicado: (2013)

Head and neck vessel magnetic resonance angiography appearance and artifacts after therapeutic intravenous ferumoxytol infusion
por: Hanreck, James Cody, et al.
Publicado: (2023)

Ferumoxytol Labeling of Human Neural Progenitor Cells for Diagnostic Cellular Tracking in the Porcine Spinal Cord with Magnetic Resonance Imaging
por: Lamanna, Jason J., et al.
Publicado: (2016)

Functionalization of gadolinium metallofullerenes for detecting atherosclerotic plaque lesions by cardiovascular magnetic resonance
por: Dellinger, Anthony, et al.
Publicado: (2013)

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
por: Fontana, Marianna, et al.
Publicado: (2015)

Abnormal Diastolic Hemodynamic Forces: A Link Between Right Ventricular Wall Motion, Intracardiac Flow, and Pulmonary Regurgitation in Repaired Tetralogy of Fallot
por: Loke, Yue-Hin, et al.
Publicado: (2022)

Assessment of gadolinium deposition in the brain tissue of pediatric and adult congenital heart disease patients after contrast enhanced cardiovascular magnetic resonance
por: Zaki, Neil, et al.
Publicado: (2020)

Society for Cardiovascular Magnetic Resonance 2020 Case of the Week series
por: Johnson, Jason N., et al.
Publicado: (2021)

A Case of Ferumoxytol (Feraheme(®)) Prompting Critical Modification to Our Patient Prebreast Magnetic Resonance Imaging Questionnaire
por: Samreen, Naziya, et al.
Publicado: (2019)

Ferumoxytol-enhanced three-dimensional magnetic resonance imaging of carotid atheroma- a feasibility and temporal dependence study
por: Usman, Ammara, et al.
Publicado: (2020)

High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol
por: Shahrouki, Puja, et al.
Publicado: (2021)

Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype
por: Strijack, Bradford, et al.
Publicado: (2008)

Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance
por: Lopez, Javier E, et al.
Publicado: (2009)

Gadolinium in pediatric cardiovascular magnetic resonance: what we know and how we practice
por: Meng, Howard, et al.
Publicado: (2012)

Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance
por: Quail, Michael, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q1jsd041c1alrq7kp3d5jlf0as